Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS INC (REGN), sold 100,000 shares at $133.86 ($13.5M) on 2012-05-01, disclosed to the SEC on 2012-05-02.
Scheduled sale ($13.5M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.86 | 2,300 | $308K | 2.3% |
| 2 | $134.55 | 58,494 | $7.9M | 58.4% |
| 3 | $135.29 | 39,106 | $5.3M | 39.2% |
| 4 | $136.57 | 100 | $14K | 0.1% |
| Total | $134.83 avg | 100,000 | $13.5M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |